E70.321
Tyrosinase positive oculocutaneous albinism
Clinical Classification Guidelines
Inclusion Terms
- Albinism II
- Oculocutaneous albinism ty-pos
Medical Intelligence & Overview
Tyrosinase-positive oculocutaneous albinism is a genetic condition characterized by a reduction or absence of pigment in the skin, hair, and eyes. This condition results from a deficiency in the enzyme tyrosinase, which plays a critical role in melanin production. Melanin is the pigment responsible for the coloration in skin, hair, and eyes. Individuals with this form of albinism typically have some pigmentation, which varies in degree. The condition can affect vision and appearance but usually does not impact overall health.
Causes & Symptoms
Clinical Causes: Genetic mutations affecting the tyrosinase enzyme production Inheritance of defective genes from parents, often in an autosomal recessive pattern Mutations lead to decreased or abnormal enzyme activity, impairing melanin synthesis
Key Symptoms: Hypopigmentation of the skin, resulting in lighter skin tone relative to family members Light-colored or white hair Eye abnormalities, such as nystagmus (involuntary eye movement), strabismus (crossed eyes), or reduced visual acuity Increased sensitivity to sunlight and a higher risk of sunburn Possible refractive errors leading to vision problems Photophobia, or sensitivity to bright light
Diagnostic & Treatment
Diagnosis Path: Diagnosis is typically based on a combination of clinical examination and specialized tests. Key diagnostic steps include: - Visual assessment to identify characteristic eye features - Observation of pigmentation levels in skin and hair - Genetic testing to identify mutations in the TYR gene responsible for tyrosinase production - Laboratory tests may include melanin level analysis and enzyme activity measurements - Family history analysis is important due to genetic inheritance patterns The diagnosis confirms the presence of oculocutaneous albinism with tyrosinase positivity, indicating some residual enzyme activity.
Treatment Protocols: While there is no cure for tyrosinase-positive oculocutaneous albinism, management strategies focus on minimizing complications and improving quality of life. These include: - Regular use of broad-spectrum sunscreens and protective clothing to prevent sunburn and skin damage - Routine eye examinations, with corrective lenses to address refractive errors - Vision aids, such as glasses or magnifiers, to enhance visual functioning - Regular skin assessments to monitor for skin damage or skin cancer risks - Education on sun safety and skin protection - Counseling and support for visual challenges and cosmetic concerns - Genetic counseling available for affected families to understand inheritance and reproductive options
Clinical Advice & FAQs
Billing Guidance
Is E70.321 a billable ICD-10 code?
Yes, E70.321 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report E70.321?
Clinical documentation must specify the nature of Tyrosinase positive oculocutaneous albinism and any associated comorbidities for accurate reporting.
Cite this Clinical Reference